| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $57K | -12.9% |
| SG&A Expense | $173K | +5.4% |
| Operating Income | -$661K | -59.2% |
| Net Income | -$1.7M | -43.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $625K | +0.0% |
| Total Assets | $5.4M | +661.3% |
| Current Liabilities | $5.6M | +7.6% |
| Stockholders' Equity | -$206K | +95.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$227K | +77.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $227K | -77.4% |
| Free Cash Flow | -$227K | +77.4% |